Tourmaline Bio, Inc. (TRML) Stock Price & Growth Analysis

Quote Panel

Updated February 17, 2025

1W 7.38 % 1M -22.65 % 3M -43.60 % 1Y -62.36 %

Key Metrics

Market Cap
354.64M
Shares Outstanding
25.64M
Share in Float
15.56M
Dividende
0

Earning Date
18 Mar 2025
Price Target
13.83
Average Volume
251140
Beta
2.3434284

Range
12.12-48.31
Industry
Biotechnology
Website
https://www.tourmalinebio.com
Sector
Healthcare

Quote Panel

Updated February 17, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

155.82x

P/S Ratio

1.11x

P/B Ratio

0.0

Debt/Equity

-2146.3%

Net Margin

$-2.5

EPS

How TRML compares to sector?

P/E Ratio

Fundamentals

Relative Strength

TRML

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

TRML

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$9M

NaN%

2025-Revenue

$3.53

-352%

2025-EPS

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

50.00(261.53%)

Number of analyst

Last analyst upgrade/downgrade

BMO Capital

initialise

Previous: Not converted

2024-12-05

Now: Outperform

Cantor Fitzgerald

initialise

Previous: Not converted

2024-10-15

Now: Overweight

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.37
vs NA

Q1.23

N/A

NA
vs -4.40

Q2.23

N/A

-0.20
vs -0.00

Q3.23

N/A

-1.64
vs -0.00

Q4.23

N/A

-0.81
vs -0.37

Q1.24

N/A

-0.55
vs NA

Q2.24

N/A

-0.68
vs -0.20

Q3.24

N/A

-0.78
vs -1.64

Q4.24

N/A

-0.87
vs -0.81

Q1.25

N/A

-0.88
vs -0.55

Sales Growth

YoY

Current

Estimates

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

2.3M vs NA

Q1.24

NA vs NA

Q2.24

NA vs NA

Q3.24

NA vs NA

Return on Equity

QoQ

Q4.22

+0%

0
vs -0.00

Q1.23

-5%

-0.05
vs 0

Q2.23

+38%

0.38
vs -0.05

Q3.23

-5%

-0.05
vs 0.38

Q4.23

+1%

0.01
vs -0.05

Q1.24

-4%

-0.04
vs 0.01

Q2.24

-5%

-0.05
vs -0.04

Q3.24

-6%

-0.06
vs -0.05

Institutionnal Ownership

Earnings Growth

Quote Panel

Updated February 17, 2025

1W 7.38 % 1M -22.65 % 3M -43.60 % 1Y -62.36 %

Key Metrics

Market Cap
354.64M
Shares Outstanding
25.64M
Share in Float
15.56M
Dividende
0

Earning Date
18 Mar 2025
Price Target
13.83
Average Volume
251140
Beta
2.3434284

Range
12.12-48.31
Industry
Biotechnology
Website
https://www.tourmalinebio.com
Sector
Healthcare

Company Description

13.83USD

N/A

155.82x

1.11x

0.0

-2146.3%

$-2.5

$9M

$3.53

Earnings Growth

Latest News

N/A

155.82x

1.11x

0.0

-2146.3%

$-2.5